Cerbara I - Search Results

1

Antimalarial and antileishmanial activities of aroyl-pyrrolyl-hydroxyamides, a new class of histone deacetylase inhibitors.

Mai A, Cerbara I, Valente S, Massa S, Walker LA, Tekwani BL. Mai A, et al. Among authors: cerbara i. Antimicrob Agents Chemother. 2004 Apr;48(4):1435-6. doi: 10.1128/AAC.48.4.1435-1436.2004. Antimicrob Agents Chemother. 2004. PMID: 15047563 Free PMC article. No abstract available.

2

3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.

Mai A, Massa S, Ragno R, Cerbara I, Jesacher F, Loidl P, Brosch G. Mai A, et al. Among authors: cerbara i. J Med Chem. 2003 Feb 13;46(4):512-24. doi: 10.1021/jm021070e. J Med Chem. 2003. PMID: 12570373

3

3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.

Mai A, Massa S, Cerbara I, Valente S, Ragno R, Bottoni P, Scatena R, Loidl P, Brosch G. Mai A, et al. Among authors: cerbara i. J Med Chem. 2004 Feb 26;47(5):1098-109. doi: 10.1021/jm030990+. J Med Chem. 2004. PMID: 14971890

4

3-(4-Aroyl-1-methyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies.

Ragno R, Mai A, Massa S, Cerbara I, Valente S, Bottoni P, Scatena R, Jesacher F, Loidl P, Brosch G. Ragno R, et al. Among authors: cerbara i. J Med Chem. 2004 Mar 11;47(6):1351-9. doi: 10.1021/jm031036f. J Med Chem. 2004. PMID: 14998325

5

Histone deacetylation in epigenetics: an attractive target for anticancer therapy.

Mai A, Massa S, Rotili D, Cerbara I, Valente S, Pezzi R, Simeoni S, Ragno R. Mai A, et al. Among authors: cerbara i. Med Res Rev. 2005 May;25(3):261-309. doi: 10.1002/med.20024. Med Res Rev. 2005. PMID: 15717297 Review.

6

Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.

Aureli L, Gioia M, Cerbara I, Monaco S, Fasciglione GF, Marini S, Ascenzi P, Topai A, Coletta M. Aureli L, et al. Among authors: cerbara i. Curr Med Chem. 2008;15(22):2192-222. doi: 10.2174/092986708785747490. Curr Med Chem. 2008. PMID: 18781944 Review.

7

Thiopyrophosphoantigens: solid-phase synthesis and in vitro characterization of a new class of Vgamma9 Vdelta2 T cells activators.

Breccia P, Angeli F, Cerbara I, Topai A, Auricchio G, Martino A, Colizzi V, Poccia F. Breccia P, et al. Among authors: cerbara i. J Med Chem. 2009 Jun 25;52(12):3716-22. doi: 10.1021/jm900054u. J Med Chem. 2009. PMID: 19453173

8

In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.

Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I. Topai A, et al. Among authors: cerbara i. Bioorg Med Chem. 2012 Apr 1;20(7):2323-37. doi: 10.1016/j.bmc.2012.02.010. Epub 2012 Feb 13. Bioorg Med Chem. 2012. PMID: 22386984 Free article.

9

GPR55: Current knowledge and future perspectives of a purported "Type-3" cannabinoid receptor.

Moriconi A, Cerbara I, Maccarrone M, Topai A. Moriconi A, et al. Among authors: cerbara i. Curr Med Chem. 2010;17(14):1411-29. doi: 10.2174/092986710790980069. Curr Med Chem. 2010. PMID: 20166924 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters